Full slide deck presented at AHA.

Final results of EVAPORATE anticipated in early 2020.

Here is the link to the EVAPORATE Abstract -

EVAPORATE Abstract - Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides (200-499mg/dl) on Statin Therapy (EVAPORATE Study)

Here is the link to the EVAPORATE Abstract -

This should help put the data into perspective. Vascepa will be looked at as an essential part of the process in preventing heart disease for those at risk. Not a bad thing at all.

Will these results help or hurt Vascepa from a labeling perspective with the FDA, which is due by December 28th?

This should help put the data into perspective. Vascepa will be looked at as an essential part of the process in preventing heart disease for those at risk. Not a bad thing at all.

42% total plaque reduction!!

5 Billion more in sales after positive EVAPORATE data sounds even better!

Liquid stent sounds good.

5 Billion more in sales after positive EVAPORATE data sounds even better!

I would love to get more context from those images but if that is an actual image from EVAPORATE that changes this entire game. Imagine Vascepa being a medicinal "liquid stent" - The science for Vascepa gets better every single day and those tired short arguments go out the window.

Liquid stent sounds good.

EVAPORATE plus this new study showing stents and bypass aren't any better than medical management are what changes the entire narrative of the Vascepa story.

Use this link, the WSJ story has a paywall.

I would love to get more context from those images but if that is an actual image from EVAPORATE that changes this entire game. Imagine Vascepa being a medicinal "liquid stent" - The science for Vascepa gets better every single day and those tired short arguments go out the window.

EVAPORATE plus this new study showing stents and bypass aren't any better than medical management are what changes the entire narrative of the Vascepa story.

I would love to get more context from those images but if that is an actual image from EVAPORATE that changes this entire game. Imagine Vascepa being a medicinal "liquid stent" - The science for Vascepa gets better every single day and those tired short arguments go out the window.

Here is an image from EVAPORATE that was posted during the AdCom yesterday. Study is presented this upcoming Monday.

Will the results of EVAPORATE be included at AdCom or does the embargo take precedence?

Here is an image from EVAPORATE that was posted during the AdCom yesterday. Study is presented this upcoming Monday.